Fox Run Management, L.L.C. Penumbra Inc Transaction History

Fox Run Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$220.09 - $273.15 $720,134 - $893,746	3,272 Added 113.22%	6,162 $1.38 Million
Q4 2023 Feb 13, 2024	BUY	$181.44 - $260.22 $115,758 - $166,020	638 Added 28.33%	2,890 $726,000
Q3 2023 Nov 07, 2023	BUY	$240.69 - $338.77 $542,033 - $762,910	2,252 New	2,252 $544,000
Q3 2021 Nov 15, 2021	SELL	$250.72 - $291.24 $244,201 - $283,667	-974 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$235.0 - $310.7 $251,450 - $332,449	-1,070 Reduced 52.35%	974 $267,000
Q2 2019 Jul 17, 2019	SELL	$124.65 - $167.39 $385,168 - $517,235	-3,090 Reduced 60.19%	2,044 $327,000
Q1 2019 Oct 17, 2019	BUY	$115.84 - $160.31 $594,722 - $823,031	5,134 New	5,134 $755,000

409

29.2M

254K

43.3K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $11.5B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.